Plasmid Construction and Transfection -The expression vector, pcDNA3-HA-HBx, was constructed as follows. A 475bp HBV subtype adr CDS fragment was subcloned into an EcoR I/Xho I site of a pcDNA3-HA tagged vector, and then CMV promoter DNA in the vector was replaced with an HBV Xgene authentic promoter DNA derived from a pHEX1 vector. HepG2 cells were plated in 6-well culture plates for 24 hr prior to transfection. Cells were transfected with 3 μg of pcDNA3-HA-HBx constructs using a Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions. After 48 hr, cells were trypsinized and plated in a medium containing 1000 μg/ml G418. Following selection for 2 weeks, total populations of G418-resistant cells were pooled and single-cell sorted into 96-well plates with a growth medium containing 1000 μg/ml G418. Sorted single cells were grown under selection for an additional 2 weeks and expanded into stable cell lines. The candidate clones were analyzed by western blot analysis using a specific HA-antibody (Roche), and by RT-PCR analysis with a specific HBx primer.
Premix Ex Taq (TaKaRa) and sets of gene-specific primers. The resulting mixture was subjected to realtime RT-PCR quantification with the Exicycler TM 96 detection system (Bioneer Corp.). Primers for PCR were designed using the Primer3 software program. The specificity of primers was verified by BLAST analysis of the mouse and human genome, visualized by RT-PCR products after agarose gel electrophoresis, and analyzed by the melting point of the PCR products. Sequences for primers used for this study are provided as supplemental information (Supplemental Table 2 ).
Western Blot Analysis -We homogenized liver tissues and cell lysates in a lysis buffer (20 mM HEPES, 150 mM NaCl, 2 mM EGTA, 1 mM EDTA, 20 mM glycerol phosphate, 1% Triton X-100 and 10% glycerol) with protease (Sigma) and a phosphatase-inhibitor cocktail (Roche PI 3-Kinase Activity -PI3K activity associated with IRS-1, IRS-2 was determined as reported (1).
Metabolic Measurements -The glucose tolerance test, insulin tolerance tests, pyruvate challenge, hepatic glucose production, immunoblotting, and serum metabolic parameter analyses were performed in accordance with standard or published protocols (2) . Blood was collected via a tail bleed in mice in the fed state between 8 and 10 a.m. Blood glucose was measured using a GlucheFine glucose meter (KMH Corp.). Serum concentrations of insulin and glucagon were measured using an insulin ELISA kit (Shibayagi) and glucagon EIA kit (Alpco Diagnostics) respectively. Plasma concentrations of triglyceride, total cholesterol, non-esterified fatty acid, alanine aminotransferase (ALT), aspartate aminotransferase (AST), high-density lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol were determined enzymatically using reagents from Wako Pure Chemical Industries Ltd. (Japan) on a Hitachi 7600-110 automatic analyzer (Hitachi High-Technologies Co.). For the glucose tolerance tests, mice were fasted overnight, and glucose (2 g/kg of body weight) was administered intraperitoneally. For the insulin tolerance tests, mice were fasted for 5 hr, and human insulin (1 IU/kg of body weight; Humulin R, Lilly) was administered intraperitoneally. For the pyruvate tolerance tests, mice were fasted for 24 hr, and pyruvate (2 g/kg of body weight) was administered intraperitoneally. All metabolic measurements were performed with mice at 6 months of age.
Hepatic Glucose Production Analysis -Mouse primary hepatocytes were isolated using a collagenase perfusion protocol. The viable hepatocyte population was further purified by a Percoll gradient centrifugation. The cells were plated at high density on collagen I-coated Biocoat dishes (BD Biosciences) in Williams' E medium (Invitrogen) supplemented with 10% fetal bovine serum and penicillin-streptomycin-glutamine. Primary hepatocytes were plated at 100,000 cells per well in 96-well tissue culture plates and left to attach for approximately 4 hr. The cells were washed twice with phosphate-buffered saline and incubated for 1 hr in a glucose production medium (glucose-and serumfree Dulbecco's Modified Eagle's Medium, containing 20 mM sodium lactate and 2 mM sodium puruvate). The glucose in the medium was assayed with a colorimetric kit (Invitrogen) according to the manufacturer's instructions.
Hepatic Glycogen Analysis -Glycogen content in the liver was analyzed by a previously described method. Briefly, approximately 50 mg of liver sample was weighted and boiled in 400 μl of 2 N HCl for 2 hr. And then 400 μl of 2 N NaOH and 22 μl of 1 M Tris-HCl (pH 7.4) were added to neutralize the acid.
The glucosyl units from the above glycogen breakdown were measured using an Amplex Red Glucose Assay kit (Invitrogen).
Histology and PAS Staining -Liver tissues from mice were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned with 4 µm in thickness, and stained with hematoxylin-eosin. Periodic acid Schiff (PAS) stain was performed by incubating with 1% periodic acid for 10 minutes, with Schiff solution (Muto) for 10 minutes and with hematoxylin for 3 minutes.
Design and Subcloning of Short Hairpin RNAs -The oligos were annealed and inserted between the
AgeI and EcoRI sites of the lentiviral pLKO.1 puro TRC vector. We constructed two shRNAs for HBx 
